Mercury appears in some vaccines as part of a preservative called thimerosal, which has been used since the 1930s to prevent bacteria and fungi from contaminating vaccine vials. It’s not the same type of mercury found in fish or thermometers, and the amount in a vaccine dose is extremely small. Here’s what it does, why it’s there, and what the safety evidence shows.
What Thimerosal Actually Does
Some vaccines come in multi-dose vials, meaning a healthcare worker draws multiple individual doses from the same container using a needle. Every time a needle punctures that vial, there’s a small risk of introducing bacteria or fungi into the remaining liquid. Without a preservative, those microorganisms could multiply in the vial, and the next person to receive a dose could get a contaminated injection. That contamination can cause severe reactions, serious illness, or death.
Thimerosal solves this problem. At concentrations as low as 1 part in 100,000, it kills a broad spectrum of harmful microorganisms and prevents fungal growth. It’s effective enough to meet the preservative standards set by the United States Pharmacopeia, which is the body that defines drug quality benchmarks in the U.S. Federal guidelines require multi-dose injectable products to demonstrate this kind of antimicrobial protection.
Ethylmercury vs. Methylmercury
The word “mercury” covers a family of compounds that behave very differently in the body. The type people rightly worry about is methylmercury, which builds up in fish and accumulates in human tissue over time. Methylmercury has a half-life of about 1.5 months, meaning it lingers and can reach harmful levels with repeated exposure.
Thimerosal breaks down into ethylmercury, which is a fundamentally different compound. Ethylmercury has a half-life of less than one week. Your body actively excretes it through the gut rather than letting it accumulate. The distinction matters because toxicity depends not just on whether something contains mercury atoms, but on how long that compound stays in your body and where it ends up. Ethylmercury clears quickly; methylmercury does not.
Animal studies have examined whether ethylmercury from thimerosal reaches the brain. At doses comparable to what a vaccine delivers, researchers found no increase in mercury content in brain tissue. When the blood-brain barrier was artificially damaged in mice (using a compound that triggers inflammation), mercury levels in the brain did rise, but that scenario doesn’t reflect what happens in a healthy person receiving a vaccine.
What the Safety Evidence Shows
The World Health Organization’s Global Advisory Committee on Vaccine Safety has reviewed the evidence multiple times and concluded there is no evidence of mercury toxicity in infants, children, or adults exposed to thimerosal in vaccines. A large analysis using the UK’s General Practice Research Database found no association between thimerosal-containing vaccines given at 2, 3, and 4 months of age and developmental delays, neurological problems, or behavioral issues.
The WHO’s position is unambiguous: there is no scientific basis for changing immunization recommendations based on thimerosal content. That includes giving hepatitis B vaccine at birth and vaccinating low-birth-weight infants where indicated.
Why It Was Removed From Most Childhood Vaccines
In July 1999, the American Academy of Pediatrics and the U.S. Public Health Service issued a joint statement calling for thimerosal to be removed from routine childhood vaccines as soon as possible. The American Academy of Family Physicians agreed later that year.
This decision was explicitly precautionary. No evidence existed at the time of any harm caused by the low levels of thimerosal in vaccines. But public concern about mercury exposure of any kind was growing, and removing it from vaccines was seen as a straightforward way to reduce one controllable source of mercury in a world full of sources that are harder to eliminate, like mercury in certain foods and the environment. Vaccine manufacturers responded by reformulating most childhood vaccines to be thimerosal-free or to contain only trace amounts left over from the manufacturing process.
Which Vaccines Still Contain It
Today, thimerosal is largely absent from the routine childhood vaccine schedule in the United States. The main exception is certain multi-dose formulations of the flu vaccine. Single-dose versions of the flu vaccine without thimerosal are widely available if you prefer them. Outside the U.S., thimerosal-containing vaccines remain common and are actively recommended by the WHO, particularly in developing countries where multi-dose vials are essential for cost-effective immunization programs. Requiring single-dose vials everywhere would dramatically increase vaccine costs and refrigeration needs, putting immunization out of reach for millions of people.
Why Multi-Dose Vials Still Exist
Single-dose vials don’t need a preservative because the vial is used once and discarded. But they cost more to manufacture, take up more storage space, and require more cold-chain capacity. During mass vaccination campaigns or in resource-limited settings, multi-dose vials are the practical option. A single vial that provides 10 doses takes up far less refrigerator space than 10 individual vials and generates less waste. Thimerosal makes those multi-dose vials safe to use over multiple days by keeping the contents sterile after each needle puncture.
The preservative exists, in short, because it solves a real and dangerous problem: microbial contamination. The mercury it contains is a form that clears from the body quickly, is present in tiny amounts, and has been studied extensively without evidence of harm.